Targeting SARS‐CoV‐2 with Chaga mushroom: An in silico study toward developing a natural antiviral compound

The novel coronavirus (SARS‐CoV‐2) has caused large‐scale global outbreaks and mainly mediates host cell entry through the interaction of its spike (S) protein with the human angiotensin‐converting enzyme‐2 (ACE‐2) receptor. As there is no effective treatment for SARS‐CoV‐2 to date, it is imperative...

Descripción completa

Detalles Bibliográficos
Autores principales: Eid, Jehane Ibrahim, Das, Biswadeep, Al‐Tuwaijri, Majdah Mohamed, Basal, Wesam Taha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645752/
https://www.ncbi.nlm.nih.gov/pubmed/34900242
http://dx.doi.org/10.1002/fsn3.2576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645752/
https://www.ncbi.nlm.nih.gov/pubmed/34900242
http://dx.doi.org/10.1002/fsn3.2576

Ejemplares similares